Le Lézard
Classified in: Ebola virus, Health
Subject: SLS

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2022


GOTHENBURG, Sweden, Dec. 5, 2022 /PRNewswire/ --       

Zinzino group revenue increased with a total of 13%, compared with the previous year.

The revenue in November for Zinzino's sales markets increased by 13% and amounted to SEK 159.6 (140.8) million. Faun Pharma's external sales increased by 5% and amounted to SEK 5.8 (5.5) million. Overall, the Group increased revenues by 13% to SEK 165.4 (146.3) million compared with the previous year.

Accumulated revenue for January - November 2022 increased by 7% to SEK 1312.6 (1222.4) million.

Revenues were distributed as follows:

Regions, mSEK

22-Nov

21-Nov

Change

YTD 2022

YTD 2021

Change

The Nordics

27.9

32.0

-13 %

292.0

332.5

-12 %

Central Europe

38.1

24.9

53 %

262.4

205.5

28 %

East Europe

46.1

41.3

12 %

314.3

303.6

4 %

South & West Europe

19.4

15.5

25 %

149.6

129.9

15 %

The Baltics

11.0

10.3

7 %

70.5

68.5

3 %

North America

7.8

4.7

66 %

71.4

45.2

58 %

Asia-Pacific

7.8

11.5

-32 %

71.6

79.6

-10 %

Africa

1.5

0.6

150 %

8.8

0.6

1367 %

Zinzino

159.6

140.8

13 %

1240.6

1165.4

6 %

Faun Pharma

5.8

5.5

5 %

72.0

57.0

26 %

Zinzino Group

165.4

146.3

13 %

1312.6

1222.4

7 %

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA

-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand

-Africa: South Africa

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:

[email protected]

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]

This disclosure contains information that Zinzino is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 05-12-2022 11:00 CET.

 

The following files are available for download:

https://mb.cision.com/Public/10976/3677488/8f522ce9aab1e57e.pdf

2211 Pressrelease Salesreport EN

 


These press releases may also interest you

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") announced today that four abstracts with Innate's drug candidates have been accepted for the European Association of Hematology (EHA) 2024 Congress,...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for Heart Failure to its discovery portfolio...

at 00:01
America's child care supply remains flat, while child care prices continue to increase, according to a new report released today by Child Care Aware® of America (CCAoA) that highlights the burden families face accessing quality and affordable child...

at 00:01
The cost of living is Gen Zs' and millennials' top societal concern, but green shoots of optimism for the economy and their personal finances are emergingNearly nine in 10 Gen Zs and millennials say purpose is important to their job satisfaction and...

at 00:00
AmacaThera Inc, a clinical stage biotechnology company specializing in the development of advanced sustained release hydrogel formulations, has dosed its first human subject with AMT-143, the company's lead asset in non-opioid acute pain management. ...

14 mai 2024
BioArctic AB's (publ) partner Eisai today said that they expect Leqembi sales to total JPY 56.5 billion (approximately SEK 4 billion) for their fiscal year (FY) 2024 (April 2024 through March 2025). This would generate approximately SEK 360 M in net...



News published on and distributed by: